Directive 2001/83/EC, copied into the United Kingdom's Human Medicines Regulations 2012, defines a medicinal product in two limbs. By presentation: any substance presented as having properties against disease in human beings. By function: any substance that may be used in human beings to restore, correct or modify a physiological function by a pharmacological, immunological or metabolic action.
The first limb turns on what the seller says and how the product looks, so a research peptide becomes a medicine the moment a claim is made for it. The second turns on what the substance does at the amount sold, which courts decide product by product. In cases of doubt, the Directive provides, medicines law applies.
See also
Cite this page
Text
Cosmic Peptides. (2026, November 1). Medicinal product by presentation: glossary entry. Cosmic Peptides Research Library. Retrieved November 1, 2026, from https://cosmicpeptides.com/research/glossary/medicinal-product-by-presentation
BibTeX
@misc{cosmicpeptides_research_glossary_medicinal_product_by_presentation,
author = {{Cosmic Peptides}},
title = {Medicinal product by presentation: glossary entry},
howpublished = {Cosmic Peptides Research Library},
year = {2026},
month = nov,
url = {https://cosmicpeptides.com/research/glossary/medicinal-product-by-presentation},
urldate = {2026-11-01},
note = {Last reviewed 2026-11-01}
} RIS
TY - ELEC AU - Cosmic Peptides TI - Medicinal product by presentation: glossary entry T2 - Cosmic Peptides Research Library PB - Cosmic Peptides PY - 2026 DA - 2026/11/01 UR - https://cosmicpeptides.com/research/glossary/medicinal-product-by-presentation Y2 - 2026/11/01 LA - en ER -
Cite the date the page was last reviewed, November 1, 2026, as its version. Reference managers such as Zotero can save this page directly.
For in vitro laboratory research only. Not for human or veterinary use. This library describes chemistry, analytical methods and published laboratory research; it gives no guidance on use in people or animals.